 |
| Dr. Tong |
| Myron Tong, MD is the Professor of Medicine for Clinical Hepatology and the Director of Asian Liver Center at the UCLA David Geffen School of Medicine. A world-leading hepatologist, Dr. Tong has specialized in liver-disease research and treatment for more than 25 years, with a distinguished record of service to the university and community. The first to link HBV infection with liver cancer, Dr. Tong is one of the leading clinical investigators on HBV and liver diseases in Asians in the U.S. and Asia. Dr. Tong's research efforts include anti-viral treatment of patients with hepatitis B and hepatitis C, and he is heavily involved in the treatment of patients with hepatocellular carcinoma at UCLA. More
|
|
| |
|
Ask the Expert Archive |
|
|
|
|
|
CME and Independent Education |
|
|
|
|
|
Physician Resources |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
Disease Educational Content |
|
|
| |
|
|
|
|
| |
Institution Information |
| Our mission is to deliver leading-edge patient care, research, and education.
Our vision is to heal humankind, one patient at a time, by improving health, alleviating suffering and delivering acts of kindness. |
|
|
| |
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
Insurers increasingly deny coverage for all-oral hepatitis C regimens |
|
| |
06-15-2018 |
|
| |
|
|
| |
Sofosbuvir-velpatasvir-voxilaprevir effective in previously treated chronic hep C |
|
| |
06-12-2018 |
|
| |
|
|
| |
Israeli company Galmed gets positive trial results for liver drug |
|
| |
06-12-2018 |
|
| |
|
|
| |
Long-term HIV viral suppression tied to lower cancer risk |
|
| |
06-11-2018 |
|
| |
|
|
| |
View Complete News Library |
|
| |
 |
|
| |
Journal Abstracts |
|
| |
The New Direct Antiviral Agents and Hepatitis C in Thoracic Transplantation: Impact on Donors and Recipients |
|
| |
|
|
| |
Estimates of state-level chronic hepatitis C virus infection, stratified by race and sex, United States, 2010 |
|
| |
|
|
| |
Switching to tenofovir vs continuing entecavir for hepatitis B virus with partial virologic response to entecavir: a randomized controlled trial |
|
| |
|
|
| |
Acute-on-Chronic Liver Failure: Getting ready for prime-time |
|
| |
|
|
| |
Development of a novel clinical staging model for cirrhosis using the Nationwide Inpatient Sample |
|
| |
|
|
| |
Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma |
|
| |
|
|
| |
View All Articles |
|
| |
|
|
| |
Congress Calendar |
|
| |
August 10-11 |
|
| |
Advanced Hepatology Educational Summit for 3rd Year Fellows
Chicago, IL, USA |
|
| |
| |
August 19-22 |
|
| |
NCAD - National Conference on Addiction Disorders
Anaheim, CA, USA |
|
| |
| |
September 7-9 |
|
| |
GHAPP - Gastroenterology & Hepatology Advanced Practice Providers
Las Vegas, NV, USA |
|
| |
| |
September 20-23 |
|
| |
ALEH - Asociación Latinoamericana para el Estudio del Hígado (ALEH) / Latin American Association for the Study of the Liver
Punta Cana, Dominican Republic |
|
| |
| |
|
|
| |
View All Conventions |
|
| |
|
|
|
|
